Table of Contents
List of Tables
List of Figures
InVivoScribe Technologies Inc Company Overview
InVivoScribe Technologies Inc Company Snapshot
InVivoScribe Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
InVivoScribe Technologies Inc – Pipeline Analysis Overview
InVivoScribe Technologies Inc – Key Facts
InVivoScribe Technologies Inc – Major Products and Services
InVivoScribe Technologies Inc Pipeline Products by Development Stage
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc Pipeline Products Overview
B-cell Clonality Assay Kit
B-cell Clonality Assay Kit Product Overview
B-cell Immuno-Oncology Assay Kit
B-cell Immuno-Oncology Assay Kit Product Overview
Companion Diagnostic Test – Eprenetapopt
Companion Diagnostic Test – Eprenetapopt Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Gilteritinib Fumarate
LeukoStrat CDx FLT3 Mutation Assay – Gilteritinib Fumarate Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib Product Overview
LeukoStrat CDx FLT3 Mutation Assay – Quizartinib Clinical Trial
LymphoTrack Dx TRB Assay – PGM
LymphoTrack Dx TRB Assay – PGM Product Overview
MiSeqDx – Cancer Diagnostic Test
MiSeqDx – Cancer Diagnostic Test Product Overview
NGS Based Hematologic Malignancy Test
NGS Based Hematologic Malignancy Test Product Overview
T-cell Clonality Assay Kit
T-cell Clonality Assay Kit Product Overview
T-cell Immuno-Oncology Assay Kit
T-cell Immuno-Oncology Assay Kit Product Overview
InVivoScribe Technologies Inc – Key Competitors
InVivoScribe Technologies Inc – Key Employees
InVivoScribe Technologies Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
InVivoScribe Technologies Inc, Recent Developments
Oct 30, 2019: European Commission approves Astellas’ XOSPATA for patients with relapsed or refractory Acute Myeloid Leukemia with mutations detected using Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay
Jun 19, 2019: Japan’s MHLW approves Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay as the CDx for Daiichi Sankyo’s Quizartinib for treatment of Relapsed/Refractory FLT3-ITD AML. Expands use to include specimens collected in EDTA
Jun 03, 2019: Invivoscribe to exhibit at ASCO 2019
May 21, 2019: Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China
Jan 23, 2019: Invivoscribe LymphoTrack Dx Assays now available
Jan 03, 2019: Invivoscribe to present at biotech showcase 2019 in San Francisco
Nov 29, 2018: US FDA approves Invivoscribe LeukoStrat CDx FLT3 Mutation Assay as CDx and Astellas drug XOSPATA (gilteritinib fumarate) for treatment of AML patients in the US
Nov 27, 2018: Invivoscribe submits LeukoStrat CDx FLT3 Mutation Assay both in the US and Japan to support Daiichi Sankyo submissions for Quizartinib
Nov 19, 2018: Invivoscribe submits the LeukoStrat CDx FLT3 Mutation Assay to support Daiichi Sankyo submission for Quizartinib in Japan
Sep 28, 2018: Invivoscribe receives approval in Japan for its LeukoStrat CDx FLT3 Mutation Assay for the assessment of acute myeloid leukemia (AML) patients treated with Xospata (gilteritinib fumarate)
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
InVivoScribe Technologies Inc Pipeline Products and Ongoing Clinical Trials Overview
InVivoScribe Technologies Inc Pipeline Products by Equipment Type
InVivoScribe Technologies Inc Pipeline Products by Indication
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc, Key Facts
InVivoScribe Technologies Inc, Major Products and Services
InVivoScribe Technologies Inc Number of Pipeline Products by Development Stage
InVivoScribe Technologies Inc Pipeline Products Summary by Development Stage
InVivoScribe Technologies Inc Ongoing Clinical Trials by Trial Status
InVivoScribe Technologies Inc Ongoing Clinical Trials Summary
B-cell Clonality Assay Kit - Product Status
B-cell Clonality Assay Kit - Product Description
B-cell Immuno-Oncology Assay Kit - Product Status
B-cell Immuno-Oncology Assay Kit - Product Description
Companion Diagnostic Test - Eprenetapopt - Product Status
Companion Diagnostic Test - Eprenetapopt - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate - Product Status
LeukoStrat CDx FLT3 Mutation Assay - Gilteritinib Fumarate - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - Product Status
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - Product Description
LeukoStrat CDx FLT3 Mutation Assay - Quizartinib - A Phase 3 Open-label Randomized Study of Quizartinib (AC220) Monotherapy Versus Salvage Chemotherapy in Subjects with Tyrosine Kinase 3 - Internal Tandem Duplication (FLT3-ITD) Positive Acute Myeloid Leukemia (AML) Refractory to or Relapsed after First-line Treatment with or without Hematopoietic Stem Cell Transplantation (HSCT) Consolidation
LymphoTrack Dx TRB Assay - PGM - Product Status
LymphoTrack Dx TRB Assay - PGM - Product Description
MiSeqDx - Cancer Diagnostic Test - Product Status
MiSeqDx - Cancer Diagnostic Test - Product Description
NGS Based Hematologic Malignancy Test - Product Status
NGS Based Hematologic Malignancy Test - Product Description
T-cell Clonality Assay Kit - Product Status
T-cell Clonality Assay Kit - Product Description
T-cell Immuno-Oncology Assay Kit - Product Status
T-cell Immuno-Oncology Assay Kit - Product Description
InVivoScribe Technologies Inc, Key Employees
InVivoScribe Technologies Inc, Subsidiaries
Glossary